T1	Participants 0 130	A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
T2	Participants 1131 1139	excluded
T3	Participants 1997 2005	patients
T4	Participants 1305 1314	responded
